Protalix BioTherapeutics, Inc.
PLXNYSEBiological Products, (No Diagnostic Substances)US미국
30일 공시 수
1건
최근 2026.10.15
90일 내부자 순매수
0원
변동 없음
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 10건
- US미국대량보유(5%)중요도 보통2026.10.15SCHEDULE 13G · Beneficial ownership report (13G)
Protalix BioTherapeutics, Inc.PLX
SCHEDULE 13G · 2026.10.15
- US미국임원·주요주주 소유중요도 낮음2026.09.094 · Statement of changes in beneficial ownership
Protalix BioTherapeutics, Inc.PLX
Form 4 · 2026.09.09
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Protalix BioTherapeutics, Inc.PLX
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Protalix BioTherapeutics, Inc.PLX
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Protalix BioTherapeutics, Inc.PLX
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Protalix BioTherapeutics, Inc.PLX
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Protalix BioTherapeutics, Inc.PLX
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Protalix BioTherapeutics, Inc.PLX
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Protalix BioTherapeutics, Inc.PLX
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Protalix BioTherapeutics, Inc.PLX
Form 4 · 2026.09.04